Skip to main content
Clinical Trials/NCT03647371
NCT03647371CompletedNot Applicable

Thyromental Height Test as a New Method for Prediction of Difficult Intubation Using Videolaryngoscopy

Medical University of Silesia1 site in 1 country200 target enrollmentStarted: August 6, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
Thyromental height

Study Overview

Brief Summary

The purpose of this study is to assess the usefulness of the Thyromental Height Test in prediction of difficult intubation using videolaryngoscopy and double lumen endotracheal tubes in patients scheduled for elective thoracic procedures.

Detailed Description

Successful and fast intubation are crucial for the safety of general anaesthesia. Failed intubation and acute hypoxia remain among the major contributing factors of anaesthesia related deaths. Difficult intubation prevalence in literature is very inconsistent and varies between 1.5-20% of cases in general population, to even 50% in obese Thai population.

There is a number of anthropometric scales and tests used for predicting difficult intubation. However, none of them appears to be sensitive and specific enough to effectively predict difficult intubation.

Recently, simple and non-invasive test predicting difficult intubation was introduced-thyromental height test (TMHT). It shows promise as a more effective substitution for frequently cited anthropometric measures. It is based on the height between the anterior border of the thyroid cartilage and the anterior border of the mentum, measured while the patient lies in the supine position with closed mouth The main objective of the trial is to assess the clinical usefulness of TMHT in prediction of difficult intubation using videolaryngoscopy and double lumen endotracheal tubes in patients scheduled for elective thoracic surgical procedures. The secondary aim is to evaluate usefulness of other commonly used predictive tests associated with difficult intubation.

During routine, preoperative anaesthetic visit thyromental height, thyromental distance, sternomental distance and Mallampati scale score are assessed. Then, during videolaryngoscopy and intubation, score in Cormack-Lehane scale and occurrence of difficult intubation are noted.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients scheduled for elective thoracic procedures, requiring general anaesthesia, videolaryngoscopy and intubation with a Robert-Shaw type double lumen endotracheal tubes
  • •written, informed consent for participation in the trail
  • •older than 18 years

Exclusion Criteria

  • •emergency procedures
  • •visible anatomic abnormalities
  • •patients scheduled for awake fibre optic intubation
  • •lack of consent for participation in the trail

Arms & Interventions

Macintosh laryngoscope

Other

direct laryngoscope - laryngoscope with Macintosh blade

Intervention: Macintosh laryngoscopy (Procedure)

McGrath videolaryngoscope

Other

McGrath Videolaryngoscope

Intervention: McGrath MAC video laryngoscopy (Procedure)

Outcomes

Primary Outcomes

Thyromental height

Time Frame: From August 6 2018 to August 5 2019.

The height between the anterior border of the thyroid cartilage (on the thyroid notch just between the 2 thyroid laminae) and the anterior border of the mentum (on the mental protuberance of the mandible), in supine position with mouth closed, measured with a depth gauge during routine preoperative anaesthetic visit.

Secondary Outcomes

  • core in modified Mallampati test(From August 6 2018 to August 5 2019.)
  • Thyromental distance(From August 6 2018 to August 5 2019.)
  • Sternomental distance(From August 6 2018 to August 5 2019.)
  • score in Cormack-Lehane scale(From August 6 2018 to August 5 2019.)
  • distance of mouth opening(From August 6 2018 to August 5 2019.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Piotr Palaczyński

Principal Investigator

Medical University of Silesia

Study Sites (1)

Loading locations...

Similar Trials